Marshall Wace
BDSX icon

Marshall Wace’s Biodesix BDSX Stock Holding History

Marshall Wace’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Sell
116,199
-25,437
-18% -$377K ﹤0.01% 1701
2026
Q1 		$2.05M Buy
+141,636
New +$1.76M ﹤0.01% 1769
2025
Q2 		– Sell
-4,406
Closed -$55.5K – 2708
2025
Q1 		$55.5K Buy
4,406
+3,653
+485% +$70.1K ﹤0.01% 2530
2024
Q4 		$23K Buy
+753
New +$22.2K ﹤0.01% 2507

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Marshall Wace's BDSX Position: Q2 2026 in Review

Marshall Wace reduced its Biodesix (BDSX) stake by 18% in Q2 2026, selling an estimated $377K and leaving 116,199 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1701.

Marshall Wace first reported a position in BDSX in Q4 2024 and has held it in 4 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Marshall Wace held 116,199 shares of Biodesix worth $2.62M as of Q2 2026.
  • Marshall Wace sold 25,437 Biodesix shares in Q2 2026, an estimated $377K.
  • Biodesix made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1701 holding.
  • Marshall Wace first reported a position in Biodesix in Q4 2024 and has held it in 4 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.